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include autografts, allografts, and artifi-
cial bone scaffolds for tissue regenera-
tion.[1–4] Although autografts are the gold 
standard in clinical practice, they pose sig-
nificant potential complications, including 
limited bone mass, size mismatch, low 
availability, and donor site damage. Allo-
genic bone grafts also frequently lead to 
potential risks, such as disease transmis-
sion, contamination, and immunological 
rejection if donors are not adequately 
evaluated or serologically screened. For-
tunately, advancements such as lab-con-
structed bone tissue engineering (BTE) 
scaffolds containing in vitro expanded 
cells have provided promising biomimetic 
bone options for patients. However, this 
approach involves extensive ex vivo cell 
manipulation, potential tumorigenesis, 
and difficulties in therapeutic translation 
and regulatory approval.[5a] To circum-
vent these problems, utilization of the 
recipient’s endogenous cells for in situ 
tissue regeneration is a practical strategy 
that eliminates the need for exogenous 
cells. This viable BTE strategy requires 
the bioscaffolds to effectively recruit host stem or progenitor 
cells to the injury site while providing a proper niche for the 
recruited cells to differentiate into bone-specific cell lineages.[5b] 
Current approaches to fabrication of nSC composites for bone tissue engi-
neering (BTE) have limited capacity to achieve uniform surface function-
alization while replicating the complex architecture and bioactivity of native  
bone, compromising application of these nanocomposites for in situ bone 
regeneration. A robust biosilicification strategy is reported to impart a 
uniform and stable osteoinductive surface to porous collagen scaffolds. The 
resultant nSC composites possess a native-bone-like porous structure and 
a nanosilica coating. The osteoinductivity of the nSC scaffolds is strongly 
dependent on the surface roughness and silicon content in the silica coating. 
Notably, without the use of exogenous cells and growth factors (GFs), the 
nSC scaffolds induce successful repair of a critical-sized calvarium defect in 
a rabbit model. It is revealed that topographic and chemical cues presented 
by nSC scaffolds could synergistically activate multiple signaling pathways 
related to mesenchymal stem cell recruitment and bone regeneration. Thus, 
this facile surface biosilicification approach could be valuable by enabling 
production of BTE scaffolds with large sizes, complex porous structures, 
and varied osteoinductivity. The nanosilica-functionalized scaffolds can be 
implanted via a cell/GF-free, one-step surgery for in situ bone regeneration, 
thus demonstrating high potential for clinical translation in treatment of 
massive bone defects.
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/adma.201904341.
Reconstruction of massive bone defects has historically been 
an enormous challenge for both patients and orthopedic 
surgeons. Suitable materials for bone defect repair primarily 
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Incorporation and administration of various growth factors 
(GFs) into these bioscaffolds have been commonly used to 
improve mesenchymal stem cell (MSC) recruitment and bone 
healing, but concerns still exist regarding the risks of GF use, 
such as their short half-life, high price, rapid degradation, 
immunogenicity, and possible toxicity and tumorigenicity.[6] 
Consequently, it is particularly challenging and significant to 
develop an ideal cell- and GF-free scaffold that can recruit host 
cells and promote osteogenesis upon implantation.
Nanocomposite biomaterials can mimic the unique micro-
environmental signals present in the bone extracellular matrix 
(ECM), providing various structural, mechanical, and biological 
cues to guide survival, proliferation, and proper differentiation 
of MSCs. Bone ECM can serve as a unique nanocomposite con-
sisting of natural collagen (mainly collagen type I, COL1) fibers 
and inorganics. Osteoinductive materials with native bone ECM 
components have been orchestrated to create collagen/inor-
ganic composites. These synthetic bone grafts have attracted sig-
nificant attention due to their ability to mimic the biochemical 
composition, biophysical structure, and mechanical properties 
of native bone ECM.[7] Silicon (Si) is an essential trace element 
required for metabolic processes associated with connective 
tissue development and bone metabolism.[8] The significant 
roles Si ions have in triggering osteogenic differentiation of 
MSCs include promoting bone matrix deposition and minerali-
zation and recruiting MSCs. To avoid the issues associated with 
the resorbability and brittleness of hydroxyapatite-collagen scaf-
folds, silica has become a potential alternative or supplement 
to hydroxyapatite due to its similar osteoinduction capacity.[8c] 
Current strategies for silicification of collagen scaffolds, such 
as bulk silica modification and intrafibrillar silicification, 
have been well-developed to fabricate osteogenesis-enhancing 
silica-collagen composites.[1,9a,b] These strategies often utilize 
a polyamine to catalyze silica polymerization and control the 
morphology and structure of silica oxide complexes.[9c,d] How-
ever, to form a continuous and stable silica layer, a high den-
sity of organic compounds must be deposited on the surface of 
the material (the higher the degree of surface modification, the 
greater the silica coverage).[9e,f ] In addition, most Si-containing 
inorganics are encapsulated by the collagen matrix of silica-col-
lagen composites, severely limiting adequate release of the Si 
ions and their direct interaction with surrounding cells. More 
importantly, these silica-collagen composites cannot precisely 
recapitulate the natural bone with respect to the intricate sur-
face topographies and hierarchical porous architectures that are 
critical to sustain cell–material biophysical interactions.[10]
Herein, we developed a robust functionalization strategy 
through a facile surface silicification process to fabricate porous 
nanosilica-collagen (nSC) scaffolds derived from porcine dem-
ineralized cancellous bone (DCB) to promote bone regeneration 
without the need for cells or GFs (Figure 1). The nanosilica-
modified collagen possesses inherent hierarchical pores with a 
sturdy nanoroughened surface, an organic-collagen/inorganic-
silica composition, and enhanced mechanical properties. As 
verified by in vitro and in vivo experimental results, the biophys-
ical and biochemical cues presented by nSC scaffolds provide a 
structurally and chemically biomimetic microenvironment that 
promotes host MSC recruitment, proliferation, and osteogen-
esis for superior bone defect repair. The benefits of this strategy 
are as follows: (1) The facile surface biosilicification generates 
uniform and complete internal and external surface coverage of 
a nanosilica coating throughout the complex porous structure 
of the collagen scaffold; (2) The topographically and chemically 
biomimetic surface endows nSC composites with high osteoin-
ductivity to promote host MSC recruitment and proliferation, 
osteogenesis, and matrix mineralization; (3) One-step surgical 
implantation can effectively repair large defects in rabbit calva-
rium through endogenous bone regeneration without the use 
of exogenous MSCs or GFs. We believe that this robust, effec-
tive, and simple biosilicification strategy could be universally 
applicable in development of BTE scaffolds with a large size 
and complex structure for enhanced in situ bone regeneration, 
and these scaffolds have great clinical translation potential for 
treatment of massive bone defects.
Although porcine DCB possesses open and intercon-
nected pores beneficial for BTE applications, its osteoinduc-
tivity is limited by a smooth collagen surface and by depletion 
of inorganic substances and osteogenic proteins secondary 
to the demineralization and deproteinization processes that 
remove immunogenic material. Therefore, we used a prefab-
ricated collagen scaffold derived from porcine DCB as a tem-
plate for in situ surface biosilicification using three types of 
silica precursors: (3-aminopropyl)trimethoxysilane (APTMS), 
(3-mercaptopropyl)trimethoxysilane (MPTMS), and tetrameth-
oxysilane (TMS), and the resultant scaffolds were referred to as 
AP-nSC, MP-nSC, and T-nSC, respectively.
To prepare a uniform and sturdy functionalized surface with 
enhanced osteoconductivity, it is necessary to form a continuous 
and stable silica coating to control the topographic features and 
the amount of silica coating (the higher the surface modifica-
tion density, the better the silicon coating coverage). Therefore, 
we adopted a straightforward LBL method. Three bilayers of 
PDADMAC/PAA-g-AB were first adsorbed to the surface of a 
DCB scaffold, and then, DMAEMA was polymerized onto the 
surface via ATRP. Subsequently, silica polymerization was 
induced to produce positively charged amino groups under rel-
atively mild conditions (Figure 1). The pure DCB scaffold (neg-
ative control) exhibited a highly open, interconnected porous 
structure, with an average pore size of 344.2 ± 83.8 µm and 
a porosity of 88.8 ± 4.5%. These specific hierarchical pores of 
DCB-derived scaffolds are critical for cell infiltration, osteogen-
esis, and tissue in-growth. Larger pore sizes (>300 µm) in nSC 
composites are beneficial for new bone and capillary regenera-
tion, while smaller pores have been shown to result in hypoxic 
conditions that induce chondrogenesis.[11] AP-nSC, MP-nSC, 
and T-nSC scaffolds exhibited similar pore morphology, pore 
size (399.9 ± 78.2, 347.6 ± 72.5, and 385.6 ± 91.6 µm, respec-
tively), and porosity (89.1 ± 4.5, 85.6 ± 4.0, and 88.4 ± 5.2%, 
respectively) (Figures S1 and S2, Supporting Information), 
suggesting that the biosilicification process produced minimal 
disruption to the porous architecture and therefore the nSC 
composites preserved the natural bone-like porous architecture 
of the untreated DCB collagen scaffold.
The surface topography and roughness of collagen scaffolds 
are critical to replicating the complex architecture of natural 
bone.[12] Upon nanosilica functionalization, the collagen scaffold 
surfaces exhibited rougher topography relative to control DCB, 
verified by scanning electron microscopy (SEM) and atomic 
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force microscopy (AFM) imaging (n = 5, p < 0.05) (Figure 2A,B). 
X-ray photoelectron spectroscopy (XPS) confirmed surface 
silicification by showing the presence of Si peaks with varying 
intensities in the nSC composites and the expected absence 
of these peaks in the DCB scaffold (Figure 2C; Figure S3 and 
Table S1, Supporting Information). Among the nSC scaf-
folds, T-nSC had the richest deposition of silica, which can 
be explained by the negative charge of silanol groups induced 
through hydrolysis of TMS, which may facilitate interaction 
with the superficial PDMAEMA that contains positively charged 
tertiary amines.[13] In contrast, the positive charge of the amino 
groups in APTMS is believed to have severely hindered silica 
deposition onto the PDMAEMA template due to charge repul-
sion, leading to reduced silica deposition onto the AP-nSC scaf-
fold surfaces. Semiquantitative analysis results showed that the 
surface roughness of the scaffolds decreased in the following 
order: T-nSC > MP-nSC > AP-nSC > DCB, which is consistent 
with the extent of silicon deposition (Figure 2D). Notably, in 
contrast with traditional surface modification methods (e.g., 
plasma treatments), this biosilicification approach resulted 
in omnidirectional nanosilica coating throughout the entire 
scaffold surface. Energy-dispersive X-ray spectroscopy (EDS) 
elemental mapping demonstrated that cross-sectional surfaces 
of the scaffolds contained amounts of Si similar to those found 
on the exterior surface of the scaffolds (Figure S4, Supporting 
Information). These findings demonstrate that this facile bio-
silicification process yielded excellent and uniform distribution 
of silica throughout the porous scaffolds. The complete sur-
face coverage of the silica coating is particularly important in 
fabricating osteoinductive scaffolds with a large size and com-
plex structures for application in large bone defect repair.
The nanosilica coating significantly enhanced the mechan-
ical properties of the nSC composites (Figure 3A,B; Figure S5, 
Supporting Information). The hardness and reduced mod-
ulus of DCB (7.0 ± 3.2 MPa and 0.3 ± 0.1 GPa, respectively) 
increased significantly with addition of the silica coating 
(n = 5, p < 0.05). The highest hardness and reduced modulus 
values were found for the T-nSC scaffold (32.9 ± 0.1 MPa and 
1.0 ± 0.2 GPa, respectively). Scaffold sturdiness (i.e., high hard-
ness and reduced modulus) can prevent early collapse, enabling 
sustainable release of Si ions and facilitating accessibility of cell 
substrates, which are necessary for nSC scaffolds to be effective 
in BTE applications in mechanically challenging physiological 
environments. As expected, the DCB, AP-nSC, MP-nSC, and 
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Figure 1. Scheme of nanosilica modification process on the surface of collagen scaffolds and the cell-free, one-step implantation approach for bone 
defect repair. (I) Layer-by-layer (LBL) adsorption of poly(diallyldimethylammonium chloride) (PDADMAC)/poly(acrylic acid-g-alkyl bromide) (PAA-g-AB) 
on the porous collagen scaffold as a template; (II) 2-(dimethylamino)ethyl methacrylate (DMAEMA) is polymerized via atom transfer radical polymeri-
zation (ATRP); (III) polymerization of silica precursors is initiated to obtain homogeneously modified nSC scaffolds; (IV) implantation of the cell-free 
functionalized collagen scaffold enhances bone regeneration by improving host MSC recruitment and osteogenesis.
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T-nSC scaffolds exhibited various Si ion release kinetic behav-
iors (Figure 3C), with mean release concentrations of 2.73, 
7.63, 16.04, and 24.61 µg mL−1, respectively, at day 21 in culture 
medium, far below the toxic level (200 µg mL−1).[14] Live/Dead 
staining of bone marrow MSCs (BMMSCs) seeded on scaffolds 
was performed after incubation for 3 d. As shown in Figure 3D, 
a high percentage of the BMMSCs were viable and adhered 
along the pore walls (Figure S6, Supporting Information), indi-
cating the biocompatibility and biosafety of nanosilica-modified 
collagen scaffolds.
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Figure 3. A) Hardness and B) reduced modulus of DCB and nSC scaffolds (n = 5, *p < 0.05, **p < 0.01; #p < 0.05 compared with DCB at matching time 
points). C) In vitro Si ion release profiles of DCB and nSC scaffolds. D) Live/Dead staining to assess viability of cells cultured on DCB and nSC scaffolds.
Figure 2. A) FESEM and B) AFM images showing the surface topologies of DCB, AP-nSC, MP-nSC, and T-nSC scaffolds. C) XPS analysis of the silicon 
atomic percentage in the scaffolds. D) AFM analysis of the surface roughness of the scaffolds (n = 5). #p < 0.05 compared with DCB at matching time 
points.
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The topographic and chemical cues presented by scaffold 
surfaces significantly affect cell–material interactions, such as 
adhesion, spreading, and differentiation.[15] After BMMSCs 
were cultured in osteogenic medium without dexamethasone 
for 21 d, BMMSC osteogenesis was verified by assessing the 
in vitro expression levels of bone-specific genes, including 
runt-related transcription factor (Runx2), alkaline phosphatase 
(ALP), osteocalcin (OCN), and collagen type I (COL1). To reveal 
the influence of the nanosilica coating on BMMSC spreading 
in the scaffolds, we used calcein AM to stain the cytoplasm and 
calculate the virtual surface area of the cells. With increasing 
Si content and surface features (T-nSC > MP-nSC > AP-nSC > 
DCB), the BMMSCs in the nSC composites displayed larger 
cell surface areas at day 7 (Figure 4A) and greater osteogenic 
gene expression levels at days 7 and 14 compared with those 
in DCB (Figure 4B,C; Table S2, Supporting Information). The 
cell spreading and osteogenic gene expression levels followed 
the same order as the silicon content and surface roughness, 
which strongly supports the notion that the nanosilica-modified 
collagen scaffolds effectively improve cell–material interactions 
and promote osteogenic differentiation of BMMSCs.
Single and double stimulus culture models were utilized to 
further distinguish the effects of Si ions and surface rough-
ness of the nSC scaffolds on the proliferation and osteogen-
esis of BMMSCs. The single-stimulus culture method solely 
tested the response to Si ions and demonstrated a similar cell 
proliferation rate among the nSC composite and DCB groups. 
In contrast, the double-stimulus model, in which response 
to stimulus with both Si ions and roughened surfaces was 
assessed, showed significantly higher cell proliferation rates 
in all nSC composite groups than in the DCB groups after 
7 d, with T-nSC fostering the highest cell proliferation rate 
(Figure 5A). Although high concentrations of Si ions in the 
single-stimulus culture obviously induced BMMSCs to pro-
duce high levels of ALP activity and osteogenic markers 
(OCN and COL1), the levels of these markers were further 
increased by the double-stimulus culture (Figure 5B), sug-
gesting that the combined effects of Si ions and roughness 
on the proliferation rate and osteogenesis of BMMSCs were 
greater than that of Si ions alone. Notably, the T-nSC scaffold 
presented the highest ability to enhance BMMSC proliferation 
and osteogenesis, revealing the substantial influence of biosi-
licification of scaffold surfaces on enhanced cell proliferation 
and osteogenic differentiation.
Having achieved promising in vitro results regarding the 
osteoinductivity of nSC scaffolds for BMMSC osteogenesis, we 
further evaluated the effects of nSC scaffolds on in vivo bone 
matrix maturation by examining calcified matrix deposition in 
a subcutaneous implantation nude mouse model. Semiquan-
titative analysis of Alizarin Red staining revealed that T-nSC 
scaffolds supported the highest and most uniform calcium 
deposition, followed by MP-nSC scaffolds with intermittent 
calcium deposition, and AP-nSC scaffolds with sparse calcium 
deposition (87.5 ± 1.4, 39.4 ± 3.3, and 18.9 ± 0.9%, respectively) 
(Figure 6A,B). Calcium deposition was shown to be minimal on 
the noncoated DCB scaffold (2.1 ± 1.4%). The extent of matrix 
mineralization may be related to the contribution of the silica-
functionalized surfaces to osteogenesis induction and collagen 
production, as well as the Si ion release, which has been found 
to effectively accelerate generation of mineralized nodules.[8] 
Additionally, an abundance of negatively charged silanol groups 
(SiOH) of the nanosilica on nSC scaffolds may produce 
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Figure 4. A) 3D rendering images and B) quantitative results showing cell surface areas in scaffolds with increasing silicon content and surface rough-
ness (from DCB to T-nSC) (**p < 0.01; #p < 0.05 compared with DCB at matching time points). C) RT-PCR detection of in vitro expression of the 
bone-specific genes Runx2, ALP, OCN, and COL1 at days 7 and 14 (n = 3, *p < 0.05, **p < 0.01; #p < 0.05 compared with DCB at matching time points).
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strong interactions with mineral ions in the surrounding envi-
ronment, thus leading to increased matrix calcification.[16]
To further evaluate the nSC scaffold capacity to recruit 
host MSCs for endogenous bone regeneration, cell-free scaf-
folds were implanted into calvarium defects in rabbits. One 
week after surgery, the implanted scaffolds were retrieved 
and subjected to immunofluorescence staining to locate cells 
positive for the mesenchymal marker CD29 and negative for 
the hematopoietic marker CD45. Frozen sections and immu-
nofluorescence staining illustrated that host cells with an 
MSC phenotype (CD29+ CD45−) were present in all nSC scaf-
folds and that the number of recruited MSCs, particularly in 
the T-nSC scaffold group, exceeded that in the DCB group 
(n = 3, *p < 0.01) (Figure S7, Supporting Information). These 
results suggest a direct correlation between the extent of func-
tionalization and Si ion release and MSC recruitment, which 
might induce subsequent osteogenesis of MSCs and neo-bone 
formation. Furthermore, we implanted MSC-free scaffolds into 
calvarial defects with a critical size of 8 mm in a rabbit model 
to investigate the recruited MSC differentiation and subsequent 
regeneration of functional bone tissue. As expected, micro-CT 
analysis and the HE and MT staining results showed expe-
dited and more extensive endogenous bone regeneration in the 
nSC scaffold groups compared with the DCB control groups at 
weeks 6 and 12 after implantation (Figure 6C,D; Figure S8, Sup-
porting Information). PR staining clearly indicated maturity of 
the regenerated bone tissue (Figure 6D). Specifically, the T-nSC 
scaffolds generated more mature bone exhibiting parallel col-
lagen fibers (stained yellow-green) than MP-nSC and AP-nSC 
scaffolds, which yielded immature bone-like tissues with less 
ordered collagen fibers (stained red and partially green). In 
contrast, disorganized fibrous tissue infiltrated the DCB scaf-
fold (stained red). These results are also supported by the lit-
erature in regard to the active involvement of Si ions in matrix 
synthesis, maturation, and turnover to maintain matrix stabi-
lization.[17] Therefore, these nSC composites indeed provide a 
natural bone ECM-mimicking niche for endogenous cells to 
attach, grow, and differentiate into mature bone tissue and thus 
present a superior capacity for enhanced bone regeneration.
To explore the potential molecular mechanisms underlying 
enhancement of bone formation resulting from host MSC 
interactions with the nSC scaffold surface, we performed RNA 
sequencing (RNA-seq) to compare gene expression profiles of 
MSCs cultured with DCB and nSC scaffolds. PCA revealed that 
differential gene expression was considerably correlated with 
the type of scaffold used (Figure 7A); in other words, the type of 
scaffolds could determine the gene expression profile of MSCs 
(Table S3, Supporting Information). Among the differentially 
expressed (DE) genes, only those demonstrating an ascending 
or descending gene expression trend were selected for further 
analysis. As shown by the gene profiling results presented as 
a heatmap in Figure 7B, 450 genes were significantly upregu-
lated (P < 0.05) in an ascending order of AP-nSC and DCB < 
MP-nSC < T-nSC, while 72 genes were significantly downregu-
lated (P < 0.05) in a descending order of T-nSC < MP-nSC < 
AP-nSC and DCB. Notably, T-nSC scaffolds exhibited the most 
substantial differential gene expression compared with the 
other nSC scaffolds. GO and KEGG enrichment analyses were 
performed to reveal the biological functions of these DE genes. 
GO analysis demonstrated that the upregulated and down-
regulated genes were involved in biological adhesion, binding, 
signaling, cellular processes, biological regulation, and cell 
Adv. Mater. 2019, 31, 1904341
Figure 5. A) CCK-8 assay to assess BMMSC proliferation in single- or double-stimulus culture models (n = 4; *p < 0.05; #p < 0.05 compared with DCB 
at matching time points). B) In vitro ALP activity and OCN and COL1 secretion in single- or double-stimulus culture models after 21 d of culture in 
osteogenic medium without dexamethasone (n = 3; *p < 0.05; #p < 0.05 compared with DCB at matching time points).
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junction formation (Figure S9, Supporting Information). KEGG 
pathway analysis of the upregulated genes revealed a significant 
enrichment of signaling pathways related to cell adhesion, 
proliferation, and differentiation into osteoblasts (Figure S10, 
Figure 6. A) Alizarin Red staining images showing calcium deposition onto subcutaneous BMMSC-seeded scaffolds. B) Calcification of BMMSC-seeded 
scaffolds in nude mice at three weeks (n = 6; *p < 0.05, #p < 0.05 compared with DCB at matching time points). C) Representative 3D images of coronal 
sections of a calvarium defect in a rabbit model at 6 and 12 weeks after implantation of scaffolds without exogenous MSCs. Red circles and yellow boxes 
define the defect margins. D) Hematoxylin and eosin (HE), Masson’s Trichrome (MT), and Picrosirius Red (PR) staining demonstrating the formation of 
new bone after implantation of scaffolds in calvarium defects. Black arrows define the boundary of the defects. Lower panels present high-power views of 
the black rectangles in the upper panels (N: new bone; F: fibrous tissue; MT blue: new bone; MT bright red: mature bone; MT dark red: fibrous tissue).
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1904341 (8 of 10)
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Figure 7. A) Variations in the RNA-seq data conveyed by principal component analysis (PCA) showing a correlation between groups of scaffolds 
(circles) and gene expression profiles. The distance between groups is proportional to the difference between gene expression profiles. B) Heatmap 
and hierarchical clustering analysis of differentially expressed genes among various scaffold groups. Each row represents the expression profile of a 
tissue sample, and each column corresponds to mRNA with a log fold change ≥2 (P < 0.05). Red indicates upregulated mRNA, while green represents 
downregulated mRNA. C) Quantitative real-time PCR (RT-PCR) analysis of the RNA-Seq. The data are presented as the mean ± SD of the three experi-
ments. D) Scheme showing the proposed molecular mechanism of host MSC recruitment induced by chemical and physical cues presented by the 
nanosilica-functionalized composite surfaces to promote MSC differentiation and new bone formation. (a) MSCs and monocytes take up Si ions via 
endocytosis, and host MSCs are further recruited by the chemoattractants SDF-1 and TGF-β, secreted by monocytes; (b) MSCs express platelet-derived 
growth factor receptor (PDGFR), the receptor for the chemoattractant PDGF; (c) MSCs adhere to the nSC scaffold, triggering a series of intracellular 
osteogenesis-related signaling pathways, including the Ca2+ signaling, Wnt, MAPK, and PI3K-Akt pathways, due to the silica functionalization and 
surface features. Abbreviations are listed in the Appendix in the Supporting Information.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1904341 (9 of 10)
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Supporting Information). These pathways included ECM-
receptor interactions (ocu04512), MAPK signaling pathway 
(ocu04010), calcium signaling pathway (ocu04020), PI3K-Akt 
signaling pathway (ocu04151), and focal adhesions (ocu04510). 
On the other hand, the downregulated genes were enriched 
in cGMP-PKG signaling pathways, which regulate vascular 
smooth muscle contraction (ocu04270) (Figure S10, Supporting 
Information). From the above signaling pathways, 15 genes 
were selected for RT-PCR validation. As expected, the results 
for 13 upregulated genes (PLCE1, PDGFRA, FGFR1, MAP2K6, 
MAP3K6, ANGPT-2, ITGA5, WNT2B, RSPO1, CACNA1G, 
FZD4, ADCY2, PRKCG) and two downregulated genes 
(NPR2, ACTG2) were consistent with the above RNA-seq data 
(Figure 7C and Table S4, Supporting Information).
Based on the above data, it was speculated that host MSCs 
could be recruited to the nSC scaffolds in response to the 
release of Si ions (Figure 7D) because recent evidence suggests 
that silicic acid released from scaffolds can effectively recruit 
endogenous MSCs by promoting the release of MSC chem-
oattractants, such as stromal cell-derived factor-1 (SDF-1) and 
transforming growth factor-β1 (TGF-β1), from blood-derived 
monocytes.[9b] Moreover, the upregulation of PDGFR suggested 
that the Si ions from the nSC surface could enhance PDGFR 
expression on MSCs. Specifically, PDGFRs have an influen-
tial role in MAPK and PI3K signaling pathways that direct cell 
migration and proliferation.[18] Furthermore, the nSC scaffold 
topography and surface chemistry are believed to regulate 
multiple cellular signaling pathways to form a fine network 
that potentiates MSC recruitment, adhesion, proliferation, 
and osteogenesis, as well as vascularization and matrix miner-
alization (Figure 7D). The increased integrin binding and focal 
adhesion formation (ANGPT2, FGFR1, ITGA5, PDGFRA) can 
lead to activation of a series of signaling pathways, including 
PI3K-Akt (ANGPT2, FGFR1, PDGFRA) and MAPK (PRKCG, 
MAP2K6, MAP3K6) pathways.[19] With the help of PKC, Ca2+ 
influx into cytoplasm via calcium channels could activate the 
phospholipase C (PLCE1) and WNT/Ca2+ signaling pathways 
(WNT2B, CACNA1G, ADCY2, CACNA1G, FZD4, RSPO1).[20a] 
The cGMP-PKG signaling pathway (NPR2) downregulation 
may be the result of increased cytoplasmic Ca2+ concentra-
tions that enhance the activity of cGMP-specific phosphodi-
esterase, which consequently decreases the amount of cGMP 
and activated MEK.[20b] For concurrent endochondral ossifica-
tion with MSC osteogenesis, vascularization of the bone matrix 
is critical.[20c] Angiopoietin-2 (encoded by ANGPT2), which 
was shown to be upregulated in this study, is an established 
protein involved in angiogenesis and thus may play a role in 
driving the vascularization process in the bone matrix during 
osteogenesis.[20d] Therefore, the decrease in vascular smooth 
muscle contraction pathway proteins (NPR2, ACTG2) may be 
explained by an increase in blood flow to the bone defect area to 
promote bone healing.[18] This process has also been found to 
participate in endochondral ossification during skeletal tissue 
development.[20b]
In summary, we report a facile and feasible surface biosilici-
fication method to construct nanosilica-modified collagen scaf-
folds that achieved effective in situ bone regeneration in large 
defects in rabbit calvarium without use of exogenous MSCs 
or GFs. Careful fabrication of various silica precursors on the 
porous DCB collagen template could tailor the osteoinductivity 
of nSC scaffolds, leading to high potency. The biosilicification 
process furnished these nSC scaffolds with topographical and 
chemical cues to create an osteoinductive extracellular milieu 
that promoted host MSC recruitment and osteogenesis and 
neo-tissue mineralization. Notably, in vivo studies confirmed 
that the nSC scaffold with the highest nanosilica functionali-
zation, T-nSC, achieved excellent repair of a large calvarium 
defect without the use of exogenous MSCs or GFs. Concen-
trated release of Si ions and surface topography were shown 
to synergistically activate a series of signaling pathways asso-
ciated with osteogenesis and vascularization. With these col-
lective findings, this intriguing work provides an innovative 
and universal approach to improve the osteoinductivity of 
scaffolds with large sizes and complex structures. The excel-
lent osteoinductivity of the nanosilica-functionalized scaffolds 
allows for in situ bone regeneration through a cell/GF-free, 
one-step surgery, and thus, these scaffolds demonstrate high 
potential for clinical translation in the treatment of massive 
bone defects, while circumventing the issues associated with 
stem cell transplantation and autografting. More importantly, 
the present study provides a scientific basis and preliminary 
understanding of the biological mechanism underlying the 
effects of nSCs on in situ bone regeneration, which will pro-
vide insights and future research platforms for examining the 
effects of silicon ion- or other metallic ion-containing nano-
structures in cell–material interactions.
Experimental Section
Experimental details can be found in the Supporting Information.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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